Mechanism of Action
Copper-Dependent Gene Modulation
Copper-binding tripeptide that modulates expression of wound healing, collagen, and antioxidant genes.
Educational content only. This page is compiled from published research for reference and is not medical advice, diagnosis, or treatment. Readers should verify claims against primary sources and consult a qualified healthcare provider before making any health decisions. Full disclaimer.
Compounds
1
Total studies
96
Human studies
8
FDA approved
0
Overview
GHK-Cu is a copper-binding tripeptide (glycyl-histidyl-lysine-Cu²⁺) that acts as a signaling molecule. The bound copper is delivered to cellular enzymes and transcription factors, modulating hundreds of genes involved in wound repair, collagen synthesis, antioxidant defense, and tissue remodeling. The copper ion is essential for many metalloenzymes including lysyl oxidase (collagen crosslinking) and superoxide dismutase.
GHK-Cu (glycyl-L-histidyl-L-lysine bound to copper(II)) has one of the most extensively characterized gene-expression signatures in peptide biology. Microarray analyses have documented modulation of over 4,000 genes — with upregulation of DNA repair, antioxidant, wound healing, and stem cell genes, and downregulation of inflammatory genes. The copper component is essential: free GHK has minimal activity, and the copper-to-peptide binding delivers the metal to target cells where it serves as cofactor for lysyl oxidase, superoxide dismutase, and other metalloenzymes.
Receptor & signaling detail
GHK-Cu does not bind a classical receptor. Its effects are mediated by cellular uptake of the copper-peptide complex followed by intracellular delivery of copper to copper-dependent enzymes and transcription factors, including some with copper-sensing regulatory elements.
How it works
- 1Chelates and delivers Cu²⁺ to target cells.
- 2Modulates expression of wound repair and antioxidant genes.
- 3Supports collagen and elastin synthesis through copper-dependent lysyl oxidase.
- 4Upregulates metalloproteinases and their inhibitors (TIMPs).
- 5Reduces oxidative damage and supports antioxidant enzymes.
Downstream clinical effects
- Improved skin appearance (reduced wrinkles, firmness)
- Enhanced wound healing
- Hair follicle stimulation
- Increased collagen deposition
Documented clinical implications
- Improved skin elasticity, firmness, and wrinkle markers (topical trials)
- Enhanced wound healing in controlled human studies
- Hair follicle support in topical formulations
- Collagen synthesis upregulation in fibroblasts
Limitations & mechanism-driven side effects
- Most controlled human data is topical, not systemic
- Injectable systemic use lacks rigorous efficacy trials
- Copper overload is a theoretical concern with very high doses
- Marketed cosmetic products vary widely in concentration and formulation
Discovery & development
GHK was first isolated from human plasma in 1973 by Loren Pickart, who observed that aged plasma stimulated liver cell regeneration less than young plasma. The tripeptide was identified as the responsible factor; copper binding was characterized subsequently.
Peptides using this mechanism
Evidence status
Decades of topical cosmetic and dermatological use. Clinical data supports wound healing and skin benefits.
Frequently asked questions
Does GHK-Cu actually work for skin aging?
Yes — controlled human trials of topical GHK-Cu have shown improvements in wrinkle depth, skin firmness, and elasticity. It is one of the most evidence-supported cosmeceutical peptides.
Should GHK-Cu be injected or used topically?
Most controlled human evidence is for topical formulations. Injectable use for systemic anti-aging purposes lacks controlled data to support efficacy claims.
Can GHK-Cu regrow hair?
Topical GHK-Cu has preliminary evidence for hair-follicle support but is not FDA approved for androgenetic alopecia. Minoxidil and finasteride remain first-line evidence-based treatments.
Is copper toxicity a concern with GHK-Cu?
At cosmetic topical doses, copper toxicity is not a meaningful concern. High-dose systemic use could theoretically exceed copper homeostatic capacity, though this has not been documented at typical dosing.
Relevant best-of guides
Related articles
Peptides for Women: Safety, Benefits, and What’s Different
Deep Dive · 14 min
BPC-157 vs GHK-Cu: Healing Peptide Comparison for Tissue Repair
Comparison · 8 min
TB-500 vs GHK-Cu: Thymosin vs Copper Peptide Healing
Comparison · 8 min
Epithalon vs GHK-Cu: Telomerase Activation vs Copper-Dependent Repair
Comparison · 8 min
Best Peptides for Joint Pain: Evidence-Based Guide 2026
Guide · 10 min